Personal Genome Diagnostics
Personal Genome Diagnostics Inc. offers genome analysis of human tumors for research.
Founded
2010Personal Genome Diagnostics Inc. offers genome analysis of human tumors for research.
Personal Genome Diagnostics Inc. (PGDx) was founded with the mission to empower the fight against cancer through advanced genome analysis. The company focuses on providing comprehensive genomic insights for human tumors, primarily for research purposes. Their flagship product, the PGDx elio tissue complete test, offers rapid and actionable genomic profiling for patients with advanced cancer, analyzing over 500 solid tumor-related genes and identifying various somatic mutations. PGDx aims to revolutionize cancer treatment by enabling precise and personalized therapeutic strategies.
Notable figures affiliated with PGDx include co-founders Dr. Victor Velculescu and Dr. Luis Diaz, both renowned for their contributions to cancer genomics. The company has attracted significant investment from entities like New Enterprise Associates (NEA). Key achievements include the FDA clearance and CE-IVD marking of their comprehensive tumor profiling kit, making it a pioneering solution in the market. PGDx's impact lies in its ability to provide highly accurate genomic data, thereby facilitating more effective and personalized cancer treatments worldwide.
Companies similar to Personal Genome Diagnostics include Foundation Medicine, Personalis, Inform Genomics and EcoGenome.
Personal Genome Diagnostics was founded in 2010.
Personal Genome Diagnostics' headquarters is located in Baltimore, MD, US.
Personal Genome Diagnostics' most recent funding round was for $103M (USD) in February 2021.
As of Feb 10, 2021, Personal Genome Diagnostics has raised a total of $244.7M (USD).
Personal Genome Diagnostics has 179 employees as of Feb 5, 2024.
Inform Genomics
informgenomics.com
